Reversible pancytopenia and immunodeficiency in a patient with hereditary folate malabsorption

15Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Mutations in SLC46A1 result in a defect of the proton coupled folate transporter (PCFT) and are the basis of hereditary folate malabsorption (HFM). Patients with HFM frequently present with neurodevelopmental delay and megaloblastic anemia. Some cases may be complicated by additional lymphopenia and immunodeficiency. We report a patient with a new homozygous mutation in the SLC46A1 gene. The boy presented with early-onset pancytopenia and secondary immunodeficiency. We provide clinical and molecular observations that extend the phenotypic description of HFM and highlight diagnostic as well as therapeutic pitfalls in this rare condition. Pediatr Blood cancer

Cite

CITATION STYLE

APA

Erlacher, M., Grünert, S. C., Cseh, A., Steinfeld, R., Salzer, U., Lausch, E., … Speckmann, C. (2015). Reversible pancytopenia and immunodeficiency in a patient with hereditary folate malabsorption. Pediatric Blood and Cancer, 62(6), 1091–1094. https://doi.org/10.1002/pbc.25364

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free